Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Compare common budgeting styles against your income and goals to determine the best fit. A practical guide to choosing effectively.
24,607 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
A bold move by Berkshire Hathaway’s new leadership shifted power in the tech landscape. This is how Greg Abel built b...
Marvell Technology shares surprised investors with a notable intraday uptick amid improving sentiment for semiconduct...
A shift in AI hardware could redefine winners and losers in tech investing. Here’s how ASICs may outpace GPUs and whi...
The quantum race isn’t only about qubits. Behind every breakthrough is a critical, unglamorous layer of infrastructur...
A quiet, strategic move by Warren Buffett's Berkshire Hathaway placed a small bet on The New York Times. Here’s what ...
Klarna stunned the market on Thursday with a rally following solid quarterly results. This article unpacks the driver...
Traditional media is fading as a pillar of democratic information, pushing investors to rethink exposure and resilien...
Best Buy surprised investors with a solid earnings beat and improving margins, sending the stock higher. This article...
Celebrity wedding chatter isn’t just gossip—it's a gold mine of budget lessons. This deep dive uses Taylor Swift Trav...
Micron stock has swung on memory cycles, auto-chip demand, and big backlog talk. This article examines whether a deal...
Tom Cruise’s Digger teaser confuses viewers and even investors. This article breaks down what happened, why it matter...